Lauren M Cornall

Summary

Affiliation: Victoria University
Country: Australia

Publications

  1. doi request reprint GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes
    L M Cornall
    Biomedical and Lifestyle Diseases Unit, School of Biomedical and Health Sciences, Victoria University, Melbourne 8001, Australia
    Mol Cell Endocrinol 365:108-18. 2013
  2. doi request reprint The therapeutic potential of GPR43: a novel role in modulating metabolic health
    Lauren M Cornall
    Biomedical and Lifestyle Diseases Unit, College of Health and Biomedicine, Victoria University, PO Box 14428, Melbourne, Vic, 8001, Australia
    Cell Mol Life Sci 70:4759-70. 2013
  3. doi request reprint Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
    Lauren M Cornall
    Victoria University, College of Health and Biomedicine, Biomedical and Lifestyle Diseases Unit, Melbourne, Australia
    Expert Opin Investig Drugs 22:487-98. 2013
  4. ncbi request reprint GPR120 agonism as a countermeasure against metabolic diseases
    Lauren M Cornall
    Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University, Melbourne 8001, Australia
    Drug Discov Today 19:670-9. 2014
  5. doi request reprint Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner
    Lauren M Cornall
    Biomedical and Lifestyle Diseases Unit, School of Biomedical and Health Sciences, Victoria University, Melbourne, Australia
    Cell Physiol Biochem 28:949-58. 2011

Detail Information

Publications5

  1. doi request reprint GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes
    L M Cornall
    Biomedical and Lifestyle Diseases Unit, School of Biomedical and Health Sciences, Victoria University, Melbourne 8001, Australia
    Mol Cell Endocrinol 365:108-18. 2013
    ..In human primary myotubes PSN632408 decreased expression of PDK4 and AMPK╬▒2 mRNA in myotubes derived from obese donors. These data suggest GPR119 activation in skeletal muscle may impair fatty acid and glucose oxidation...
  2. doi request reprint The therapeutic potential of GPR43: a novel role in modulating metabolic health
    Lauren M Cornall
    Biomedical and Lifestyle Diseases Unit, College of Health and Biomedicine, Victoria University, PO Box 14428, Melbourne, Vic, 8001, Australia
    Cell Mol Life Sci 70:4759-70. 2013
    ..This review summarizes the current evidence regarding the ability of GPR43 to mediate both systemic and tissue specific functions and how GPR43 may be modulated in the treatment of metabolic disease. ..
  3. doi request reprint Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
    Lauren M Cornall
    Victoria University, College of Health and Biomedicine, Biomedical and Lifestyle Diseases Unit, Melbourne, Australia
    Expert Opin Investig Drugs 22:487-98. 2013
    ....
  4. ncbi request reprint GPR120 agonism as a countermeasure against metabolic diseases
    Lauren M Cornall
    Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University, Melbourne 8001, Australia
    Drug Discov Today 19:670-9. 2014
    ..This review summarizes the current knowledge of GPR120 functionality and the potential applications of GPR120-specific agonists for the treatment of disease states such as obesity, type 2 diabetes mellitus and cardiovascular disease. ..
  5. doi request reprint Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner
    Lauren M Cornall
    Biomedical and Lifestyle Diseases Unit, School of Biomedical and Health Sciences, Victoria University, Melbourne, Australia
    Cell Physiol Biochem 28:949-58. 2011
    ..Here, we characterise the effect of diet-induced obesity on the expression of GPR43 and GPR120 in tissues important in maintaining metabolic health...